// App-Quantinova.ai

5013 : Association of SLCO transport genes with intraprostatic abiraterone (ABI) levels and pathologic outcomes in men with high-risk localized prostate cancer (PCa).

Researchers

Presenter

  • Elahe A. Mostaghel

Principal Investigators

  • Eunpi Cho

  • Jonathan Lawrence Wright

  • Mary-Ellen Taplin

  • Alvin M. Matsumoto

  • Daniel Tamae

  • Trevor M. Penning

  • Steven P. Balk

  • Philip W. Kantoff

  • Peter Nelson

  • Robert B. Montgomery

  • Massimo Loda

  • Brett Marck

Medical Centers

  • Beth Israel Deaconess Medical Center, Boston, MA

  • Department of Pathology, Brigham and Womens Hospital, Boston, MAFred Hutchinson Cancer Rsrch Ctr, Seattle, WAUniversity of Washington Oncology, Seattle, WA

  • University of Washington, Seattle, WA

  • University of Washington School of Medicine, Seattle, WA

  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

  • University of Pennsylvania, Philadelphia, PA

  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

  • VA Puget Sound Healthcare System III, Seattle, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Apoptotic body index

Drug/Treatment

  • CB-7598

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved